Beijing Avistone Pharmaceuticals Biotechnology Co.
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $341M
Investors
- 7
About Beijing Avistone Pharmaceuticals Biotechnology Co.
Founded in 2018 and based in Beijing, China, Beijing Avistone Pharmaceuticals Biotechnology Co. Ltd. operates as a clinical-stage biotechnology company. Dr. Hepeng Shi is the founder and CEO of the company as of 2021., Ltd. The company has focused on developing precision oncology therapies for more than a decade and has a large oncology pipeline with a focus on lung cancer treatments. A c-Met inhibitor is in late-stage clinical development for genetically defined populations of non-small cell lung cancer (NSCLC) and glioblastoma (GBM).
Who invested in Beijing Avistone Pharmaceuticals Biotechnology Co.
7 investors across 2 rounds
See all investors in Beijing Avistone Pharmaceuticals Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing Avistone Pharmaceuticals Biotechnology Co.
Who invested in Beijing Avistone Pharmaceuticals Biotechnology Co.?
Beijing Avistone Pharmaceuticals Biotechnology Co. has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Avistone Pharmaceuticals Biotechnology Co. raised?
Beijing Avistone Pharmaceuticals Biotechnology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Avistone Pharmaceuticals Biotechnology Co. last raise money?
Beijing Avistone Pharmaceuticals Biotechnology Co.'s most recent round on record is a Series B, in Dec 2023.
What does Beijing Avistone Pharmaceuticals Biotechnology Co. do?
Founded in 2018 and based in Beijing, China, Beijing Avistone Pharmaceuticals Biotechnology Co.
Where is Beijing Avistone Pharmaceuticals Biotechnology Co. headquartered?
Beijing Avistone Pharmaceuticals Biotechnology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Avistone Pharmaceuticals Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Beijing Avistone Pharmaceuticals Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Beijing Avistone Pharmaceuticals Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.